









Markets
/
Stocks
/
nasdaq-hims
/

Hims & Hers Health Inc

HIMS

49.780USD

-9.320-15.76%

Close 10/17, 16:00（ET）Quotes delayed by 15 min

11.24BMarket Cap

58.05P/E TTM



Hims & Hers Health Inc

49.780

-9.320-15.76%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Hims & Hers Health Inc

Currency: USD Updated: 2025-10-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hims & Hers Health Inc's Score

Industry at a Glance

Industry Ranking

47 / 72

Overall Ranking

242 / 4691

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 14 analysts

Hold

Current Rating

48.824

Target Price

-1.92%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Hims & Hers Health Inc Highlights

StrengthsRisks

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 180.22% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is 56.46, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 178.79M shares, decreasing 9.25% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 6.87M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.72.

Financial Health

Currency: USD Updated: 2025-10-17

The company's current financial score is 7.32, which is higher than the Healthcare Providers & Services industry's average of 7.27. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 544.83M, representing a year-over-year increase of 72.61%, while its net profit experienced a year-over-year increase of 219.66%.

Score

Industry at a Glance

Previous score

7.32

Change



Financials

8.83

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

5.55

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

6.74

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.22

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.27

Key Metrics

Free cash flow

No Data

Hims & Hers Health Inc's Company Valuation

Currency: USD Updated: 2025-10-17

The company’s current valuation score is 5.71, which is lower than the Healthcare Providers & Services industry's average of 7.12. Its current P/E ratio is 56.46, which is 51.78% below the recent high of 85.69 and 40.49% above the recent low of 33.60.

Score

Industry at a Glance

Previous score

5.71

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 47/72

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-17

The company’s current earnings forecast score is 6.14, which is lower than the Healthcare Providers & Services industry's average of 7.57. The average price target for Hims & Hers Health Inc is 48.00, with a high of 85.00 and a low of 28.00.

Score

Industry at a Glance

Previous score

6.14

Change

Support & Resistance

No Data

Analyst Rating

Based on 14 analysts

Hold

Current Rating

48.824

Target Price

-1.92%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Hims & Hers Health Inc

HIMS

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-17

The company’s current price momentum score is 6.65, which is lower than the Healthcare Providers & Services industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 60.19 and the support level at 44.49, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.03

Change

-2.38

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.018

Neutral

RSI(14)

43.429

Neutral

STOCH(KDJ)(9,3,3)

28.374

Sell

ATR(14)

4.773

High Vlolatility

CCI(14)

-138.918

Sell

Williams %R

98.853

Oversold

TRIX(12,20)

0.396

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

56.088

Sell

MA10

56.354

Sell

MA20

56.316

Sell

MA50

51.198

Sell

MA100

52.446

Sell

MA200

45.324

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-17

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 7.03. The latest institutional shareholding proportion is 82.15%, representing a quarter-over-quarter decrease of 11.06%. The largest institutional shareholder is The Vanguard, holding a total of 18.63M shares, representing 8.56% of shares outstanding, with 10.04% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

21.67M

-0.57%

The Vanguard Group, Inc.

Star Investors

18.63M

+1.05%

Capital World Investors

18.56M

+3131.84%

Dudum (Andrew)

9.43M

+0.06%

Farallon Capital Management, L.L.C.

8.21M

+3.27%

Goldman Sachs & Company, Inc.

7.54M

-2.27%

State Street Investment Management (US)

7.04M

-5.41%

Renaissance Technologies LLC

Star Investors

6.87M

-2.21%

Geode Capital Management, L.L.C.

4.75M

+1.53%

Morgan Stanley & Co. LLC

4.05M

+14.65%

Risk Assessment

Currency: USD Updated: 2025-10-17

The company’s current risk assessment score is 3.93, which is lower than the Healthcare Providers & Services industry's average of 5.58. The company's beta value is 2.22. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.